TY - JOUR
T1 - Reasons for delayed treatment initiation in Guillain-Barre syndrome
AU - Kenan, Gilad
AU - Regev, Tomer
AU - Kushnir, Mark
AU - Cohen, Oren
AU - Gandelman-Marton, Revital
AU - Kimiagar, Itzhak
AU - Armon, Carmel
N1 - Publisher Copyright:
© 2022
PY - 2022/3/15
Y1 - 2022/3/15
N2 - Objective: The goal of this study was to analyze the reasons for delayed diagnosis of Guillain-Barre syndrome (GBS). Methods: We retrospectively reviewed the records of all adult patients with GBS treated at Shamir Medical Center (SMC) from 2006 to 2018. We divided the patients into two groups: those with early initiation of treatment (within 24 h of arrival to ED), and those with later initiation of treatment (>24 h after arrival). We extracted epidemiological and clinical data regarding those groups, and compared them. Results: 100 patients with GBS were treated between 2006 and 2018 at SMC. 50 patients were treated within 24 h of arrival, and in 50 - treatment was initiated later. Of those with delayed treatment, 9 had mild disease, but did receive a working diagnosis of GBS. 41 patients were not diagnosed initially as a clear-cut GBS, and alternative diagnoses were considered, the most common were orthopedic (11/41), vascular (7/41) or nutritional deficiency (6\41). Findings that increased the likelihood for alternative diagnoses to be considered first were severe limb or back pain (26/41); intact or brisk reflexes (17/41); and an atypical pattern of weakness (7\41). Conclusions: GBS is a challenging diagnosis. Acknowledging the heterogeneity of its presentation and knowing its pitfalls is crucial for the prompt and accurate diagnosis of the disease.
AB - Objective: The goal of this study was to analyze the reasons for delayed diagnosis of Guillain-Barre syndrome (GBS). Methods: We retrospectively reviewed the records of all adult patients with GBS treated at Shamir Medical Center (SMC) from 2006 to 2018. We divided the patients into two groups: those with early initiation of treatment (within 24 h of arrival to ED), and those with later initiation of treatment (>24 h after arrival). We extracted epidemiological and clinical data regarding those groups, and compared them. Results: 100 patients with GBS were treated between 2006 and 2018 at SMC. 50 patients were treated within 24 h of arrival, and in 50 - treatment was initiated later. Of those with delayed treatment, 9 had mild disease, but did receive a working diagnosis of GBS. 41 patients were not diagnosed initially as a clear-cut GBS, and alternative diagnoses were considered, the most common were orthopedic (11/41), vascular (7/41) or nutritional deficiency (6\41). Findings that increased the likelihood for alternative diagnoses to be considered first were severe limb or back pain (26/41); intact or brisk reflexes (17/41); and an atypical pattern of weakness (7\41). Conclusions: GBS is a challenging diagnosis. Acknowledging the heterogeneity of its presentation and knowing its pitfalls is crucial for the prompt and accurate diagnosis of the disease.
KW - Acute inflammatory demyelinating polyneuropathy
KW - Delayed diagnosis
KW - GBS
KW - IVIG treatment
UR - http://www.scopus.com/inward/record.url?scp=85123957295&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2022.120179
DO - 10.1016/j.jns.2022.120179
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35124414
AN - SCOPUS:85123957295
VL - 434
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
SN - 0022-510X
M1 - 120179
ER -